November 2, 2016Open Access

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Key Points

Key points are not available for this paper at this time.

Abstract

Antenatal ART resulted in significantly lower rates of early HIV transmission than zidovudine alone but a higher risk of adverse maternal and neonatal outcomes. (Funded by the National Institutes of Health; PROMISE ClinicalTrials.gov numbers, NCT01061151 and NCT01253538 .).

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Key Points

Abstract

Cite This Study

Also Consider

Also Consider